Name: DuPont de Nemours Inc. (NYSE:DD) | Analysis of Revenues
Creator: Stock Analysis on Net

Analysis of Revenues

Revenues as Reported

Revenues as Reported

Download chart

DuPont de Nemours Inc., income statement, revenues

US$ in millions

12 months ended:	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Agriculture	—)	14,301)	7,516)	6,173)	6,327)
Performance Materials & Coatings	—)	9,575)	8,783)	6,412)	4,517)
Industrial Intermediates & Infrastructure	—)	15,116)	12,647)	10,832)	13,691)
Packaging & Specialty Plastics	—)	24,096)	21,456)	18,404)	18,357)
Electronics & Imaging	3,554)	4,720)	3,356)	2,307)	1,987)
Nutrition & Biosciences	6,076)	6,801)	2,812)	975)	1,029)
Transportation & Industrial	4,950)	5,620)	2,521)	897)	583)
Safety & Construction	5,201)	5,453)	3,006)	1,877)	1,938)
Non-Core	1,731)	295)	387)	281)	349)
Net trade revenue	21,512)	85,977)	62,484)	48,158)	48,778)

Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31).

Net trade revenue experienced a period of substantial expansion between 2015 and 2018, increasing from US$ 48,778 million to US$ 85,977 million, before undergoing a precipitous decline to US$ 21,512 million by the end of 2019. This trajectory indicates a significant structural reorganization of the company's portfolio.

Growth Phase Analysis (2015–2018): During this period, a broad upward trend was observed across nearly all business segments. Packaging & Specialty Plastics remained the largest contributor, growing from US$ 18,357 million to US$ 24,096 million. Agriculture and Performance Materials & Coatings showed strong momentum, with Agriculture more than doubling its revenue from US$ 6,327 million in 2015 to US$ 14,301 million in 2018.
Specialized Segment Acceleration: The period between 2017 and 2018 was marked by exponential growth in several specialty divisions. Nutrition & Biosciences revenue increased from US$ 2,812 million to US$ 6,801 million, while Transportation & Industrial revenue grew from US$ 2,521 million to US$ 5,620 million. Safety & Construction followed a similar pattern, increasing from US$ 3,006 million to US$ 5,453 million within the same timeframe.
Portfolio Reconfiguration (2019): A fundamental shift in revenue composition occurred in 2019. Revenue from Agriculture, Performance Materials & Coatings, Industrial Intermediates & Infrastructure, and Packaging & Specialty Plastics ceased to be reported, resulting in a total net trade revenue contraction of approximately 75% compared to 2018. The remaining revenue stream became concentrated in Electronics & Imaging, Nutrition & Biosciences, Transportation & Industrial, and Safety & Construction, which collectively mirrored the values of the 2018 specialty segments with slight declines.
Non-Core Activity: Non-core revenues remained relatively stable and immaterial between 2015 and 2018, ranging between US$ 281 million and US$ 387 million. However, a significant increase was recorded in 2019, with non-core revenue rising to US$ 1,731 million, suggesting a higher volume of divestitures or discontinued operations during the restructuring phase.

AI Ask an analyst for more

My previous chats

Add tokens

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?